OSMT - Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q4 2020 Results - Earnings Call Transcript

Osmotica Pharmaceuticals plc (OSMT) Q4 2020 Results Conference Call March 30, 2021 4:30 PM ET Company Participants Lisa Wilson - Investor Relations Brian Markison - Chairman of the Board and Chief Executive Officer Andrew Einhorn - Chief Financial Officer James Schaub - Executive Vice President & Chief Operating Officer Conference Call Participants Dan Busby - RBC Capital Markets Greg Fraser - Truist Securities David Steinberg - Jefferies Presentation Operator Thank you for standing by, and welcome to the Osmotica Q4 2020 Earnings Business Update Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. As a reminder, today's conference call is being recorded. I will now turn the conference over to your host, Ms. Lisa Wilson. Ma'am, you may begin. Lisa Wilson Thank you, operator. Welcome to Osmotica Pharmaceuticals fourth quarter 2020 business update call. This

For further details see:

Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q4 2020 Results - Earnings Call Transcript